Viatris Settles EpiPen Antitrust Litigation for $264 Million – The New York Times

Neither Viatris officials nor lawyers representing the company immediately responded to a request for comment on Monday night.
Updated Feb. 28, 2022, 4:58 p.m. ET
Lynn Sarko, a lawyer representing … [+1314 chars]